# Biochemical, Molecular and Behavioral Changes Induced by High-fat and High-sugar Diets: A Systematic Review of Non-clinical Studies

**Authors:** Camila Bach, Julia Vicentin Souza, Cláudia Sirlene Oliveira, Rosiane Guetter Mello, Daniele Maria-Ferreira

PMC · DOI: 10.1007/s12035-026-05816-w · Molecular Neurobiology · 2026-03-26

## TL;DR

This review explores how high-fat and high-sugar diets affect the body and brain, leading to harmful biochemical, molecular, and behavioral changes.

## Contribution

The study systematically reviews non-clinical evidence linking high-fat/high-sugar diets to neural and physiological changes.

## Key findings

- High-fat and high-sugar diets induce physiological changes in the peripheral and central nervous systems.
- These diets are associated with changes in gut microbiota, glucose metabolism, and bile acid signaling.
- Adverse effects include neuronal and structural adaptations, suggesting a need for further research on prevention strategies.

## Abstract

Diets that promote excessive caloric intake, particularly those high in fat and/or sugar, can cause harmful changes in the human body, including the brain. Excess consumption of fat and sugar may impair neuronal function and have both short- and long-term adverse effects. This systematic review examined the influence of high-fat and/or high-sugar dietary patterns on biochemical, molecular, and behavioral changes (PROSPERO protocol number: CRD42024526471). A systematic search was conducted in PubMed, EMBASE, and Scopus, and twenty-eight articles were included for data extraction. The studies indicate that obesogenic and energy-dense dietary patterns induce physiological changes in both the peripheral and central nervous systems, leading to neuronal, functional, and structural adaptations accompanied by biochemical, molecular, and behavioral changes. These adaptations appear to be associated with coordinated changes in gut microbiota composition, glucose and insulin metabolism, and bile acid signaling pathways. These findings support further investigation into strategies for the prevention and treatment of diet-related cognitive impairment. However, additional non-clinical and clinical studies are needed to better elucidate the mechanisms linking energy-dense dietary patterns and excessive caloric intake to these neural changes.

The online version contains supplementary material available at 10.1007/s12035-026-05816-w.

## Full-text entities

- **Genes:** Dio2 (iodothyronine deiodinase 2) [NCBI Gene 65162] {aka 5DII, DIOII}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Nos3 (nitric oxide synthase 3) [NCBI Gene 24600] {aka eNos}, Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, Mcpt1l1 (mast cell protease 1-like 1) [NCBI Gene 100360872] {aka Mcpt1, rMCP-1, rMCP-I}, Cyp39a1 (cytochrome P450, family 39, subfamily a, polypeptide 1) [NCBI Gene 301264], Ppara (peroxisome proliferator activated receptor alpha) [NCBI Gene 19013] {aka 4933429D07Rik, Nr1c1, PPAR-alpha, PPARalpha, Ppar}, Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, Nos1 (nitric oxide synthase 1) [NCBI Gene 24598] {aka bNOS}, Cyp46a1 (cytochrome P450, family 46, subfamily a, polypeptide 1) [NCBI Gene 362782], Pyy (peptide YY) [NCBI Gene 287730] {aka GHYY, RATGHYY, Yy, peptide-YY}, Nr0b2 (nuclear receptor subfamily 0, group B, member 2) [NCBI Gene 117274] {aka Shp}, Dlg4 (discs large MAGUK scaffold protein 4) [NCBI Gene 29495] {aka Dlgh4, PSD95, Sap90}, Bdnf (brain-derived neurotrophic factor) [NCBI Gene 24225], Cyp27a1 (cytochrome P450, family 27, subfamily a, polypeptide 1) [NCBI Gene 301517] {aka Cyp27, P450C27}, Nr1h4 (nuclear receptor subfamily 1, group H, member 4) [NCBI Gene 60351] {aka Fxr}, Glp1r (glucagon-like peptide 1 receptor) [NCBI Gene 25051] {aka Glip, RATGL1RCP}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}
- **Diseases:** overweight (MESH:D050177), metastasis (MESH:D009362), depression (MESH:D003866), cancers (MESH:D009369), obesity (MESH:D009765), decreased learning and memory (MESH:D007859), Metabolic abnormalities (MESH:D008659), weight gain (MESH:D015430), insulin resistance (MESH:D007333), diabetes (MESH:D003920), anxiety (MESH:D001007), chronic inflammation (MESH:D007249), glucose intolerance (MESH:D018149), cardiovascular and cerebrovascular problems (MESH:D002318), gut dysbiosis (MESH:D064806), system problems (MESH:D019973), cognitive decline (MESH:D003072), metabolic syndrome (MESH:D024821), neuroinflammation (MESH:D000090862)
- **Chemicals:** salt (MESH:D012492), fructose (MESH:D005632), bile acid (MESH:D001647), sodium (MESH:D012964), cholesterol (MESH:D002784), sugar (MESH:D000073893), glucose (MESH:D005947), lipid (MESH:D008055), fat (MESH:D005223), corn starch (MESH:D013213), corticosterone (MESH:D003345), sucrose (MESH:D013395), carbohydrates (MESH:D002241)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116], Rodentia (rodent, order) [taxon 9989], Canis lupus familiaris (dog, subspecies) [taxon 9615], Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13021713/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13021713/full.md

---
Source: https://tomesphere.com/paper/PMC13021713